The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Reaching for a diet soda or artificially sweetened snack to lose weight or to enjoy a few more treats? A growing number of scientists believe that’s not a good idea.

FDA approves Zyn nicotine pouches, including 10 flavors, as a safer option for adult smokers. The decision marks the first FDA authorization for nicotine pouches, which are tobacco-free. Advocates ...

Jan 17 (Reuters) - The U.S. Food and Drug Administration has approved ... Enhertu, was first approved by the FDA in 2019 for a type of breast cancer and later expanded for use in multiple conditions.

16 (UPI) --The U.S. Food and Drug Administration on Thursday approved ... Advertisement It's the first time the FDA has approved marketing of nicotine pouches, which it describes as "small ...